Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-12-30 00:00:00 ET · period of report 2021-12-28 · accession 0001567619-21-022724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-30 | 2021-12-28 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $1.14 | +113.9K | 100.7K | New | +$129.7K |
| DM | 2021-12-30 | 2021-12-28 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $0.00 | -113.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-12-28 | M | A | 59,968 | $1.20 | 160,686 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-12-28 | M | A | 53,952 | $1.07 | 100,718 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-12-28 | M | D | 53,952 | $0.00 | 0 | D | $1.07 · — to 2026-11-18 | 53,952 Class A Common Stock | (F1) All of the shares subject to the option are fully vested and exercisable as of the date hereof. |
| 4 | Derivative | Stock Option (right to buy) | 2021-12-28 | M | D | 59,968 | $0.00 | 0 | D | $1.20 · — to 2027-10-18 | 59,968 Class A Common Stock | (F1) All of the shares subject to the option are fully vested and exercisable as of the date hereof. |